PROVIDER PROFILE · NPI 1023797917

Megan Bellavance

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

503

Beneficiaries

—

Total drug cost

$76K

Distinct drugs

Brand share

32.2%

Top prescribed drugs

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital

CROSS-REFERENCE